aequusbiopharma.com

Aequus BioPharma - Home

A proprietary recombinant DNA approach to creating novel therapeutic protein drugs by extending the plasma half-life of proteins and peptides which possess poor inherent pharmacokinetic properties. Aequus BioPharma, Inc. 3101 Western Ave. Suite 600. Seattle, WA 98121. Aequus’ GlycoPolymer technology allows scientists to create novel biopharmaceuticals that require less frequent injections (i.e., monthly rather than daily) due to their improved pharmacokinetic properties.

http://www.aequusbiopharma.com/

OVERVIEW OF aequusbiopharma.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

9

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR AEQUUSBIOPHARMA.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.5 out of 5 with 13 reviews

5 star

9

4 star

3

3 star

0

2 star

0

1 star

1

Hey there! Start your review of aequusbiopharma.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.7 seconds

CONTACTS AT AEQUUSBIOPHARMA.COM

Domains By Proxy, LLC

Registration Private

Domain●●●●●●xy.com

14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309

Sco●●●ale , Arizona, 85260

United States

1.48●●●●2599

1.48●●●●2598

AE●●●●●●●●●●●●●●●●●@domainsbyproxy.com

View this contact

Domains By Proxy, LLC

Registration Private

Domain●●●●●●xy.com

14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309

Sco●●●ale , Arizona, 85260

United States

1.48●●●●2599

1.48●●●●2598

AE●●●●●●●●●●●●●●●●●@domainsbyproxy.com

View this contact

Domains By Proxy, LLC

Registration Private

Domain●●●●●●xy.com

14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309

Sco●●●ale , Arizona, 85260

United States

1.48●●●●2599

1.48●●●●2598

AE●●●●●●●●●●●●●●●●●@domainsbyproxy.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2006 October 05
UPDATED: 2013 September 06
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

17

YEARS
7

MONTHS
12

DAYS

NAME SERVERS

1: ns17.domaincontrol.com
2: ns18.domaincontrol.com

REGISTRAR

GODADDY.COM, LLC

WHOIS : whois.godaddy.com

REFERRED : http://registrar.godaddy.com

CONTENT

PAGES IN
THIS WEBSITE

9

SSL

EXTERNAL LINKS

12

SITE IP

67.212.143.5

LOAD TIME

0.749 sec

SCORE

6.2

PAGE TITLE

Aequus BioPharma - Home | aequusbiopharma.com Reviews

<META> DESCRIPTION

A proprietary recombinant DNA approach to creating novel therapeutic protein drugs by extending the plasma half-life of proteins and peptides which possess poor inherent pharmacokinetic properties. Aequus BioPharma, Inc. 3101 Western Ave. Suite 600. Seattle, WA 98121. Aequus’ GlycoPolymer technology allows scientists to create novel biopharmaceuticals that require less frequent injections (i.e., monthly rather than daily) due to their improved pharmacokinetic properties.

<META> KEYWORDS

1 glycopolymer technology

2 learn more

3 technology

4 news

5 investors

6 about us

7 general information

8 info@aequusbio com

9 technical information

10 science@aequusbio com

CONTENT

Page content here

KEYWORDS ON PAGE

glycopolymer technology,learn more,technology,news,investors,about us,general information,info@aequusbio com,technical information,science@aequusbio com,terms of use

SERVER

Apache/2.2.29 (Unix) mod_ssl/2.2.29 OpenSSL/0.9.8e-fips-rhel5 mod_fcgid/2.3.8-dev mod_qos/10.29

CONTENT-TYPE

iso-8859-1

GOOGLE PREVIEW

Aequus BioPharma - Home | aequusbiopharma.com Reviews

https://aequusbiopharma.com

A proprietary recombinant DNA approach to creating novel therapeutic protein drugs by extending the plasma half-life of proteins and peptides which possess poor inherent pharmacokinetic properties. Aequus BioPharma, Inc. 3101 Western Ave. Suite 600. Seattle, WA 98121. Aequus’ GlycoPolymer technology allows scientists to create novel biopharmaceuticals that require less frequent injections (i.e., monthly rather than daily) due to their improved pharmacokinetic properties.

INTERNAL PAGES

aequusbiopharma.com

1

Aequus BioPharma - Home

http://www.aequusbiopharma.com/default.html

A proprietary recombinant DNA approach to creating novel therapeutic protein drugs by extending the plasma half-life of proteins and peptides which possess poor inherent pharmacokinetic properties. Aequus BioPharma, Inc. 3101 Western Ave. Suite 600. Seattle, WA 98121. Aequus’ GlycoPolymer technology allows scientists to create novel biopharmaceuticals that require less frequent injections (i.e., monthly rather than daily) due to their improved pharmacokinetic properties.

2

Aequus BioPharma - February 12, 2007 - CTI

http://www.aequusbiopharma.com/news_12Feb07.html

Cell Therapeutics, Inc. (CTI) Spin-off to Use Proprietary Recombinant Genetic Technology to Develop Novel Biopharmaceuticals, Follow-on Biologics and to Deliver siRNA. SEATTLE, Feb. 12, 2007. The Genetic Polymer technology can be used with multiple molecules, which may eliminate the need to develop individualized technology for extending the plasma half-life of each biopharmaceutical. About Cell Therapeutics, Inc. Headquartered in Seattle, CTI. SOURCE Cell Therapeutics, Inc. 02/12/2007.

3

Aequus BioPharma - May 14, 2007

http://www.aequusbiopharma.com/news_14May07.html

CTI and Aequus BioPharma to Co-Develop Genetic Polymer™ Modified G-CSF for First Follow-on Biologic Product. SEATTLE, May 14, 2007. Using Aequus' Genetic Polymer technology to create the novel human therapeutic ABQ-101 may result in greater ease of manufacture and a lower cost of goods. So we are confident we have the requisite experience in protein therapeutic development and manufacturing.". School) at the University of Washington. Additional board members will include Jack W. Singer, M.D.,...Is a biop...

4

Aequus BioPharma - // Investors

http://www.aequusbiopharma.com/investors.html

Aequus BioPharma was formed in mid 2007 as a majority-owned subsidiary of Cell Therapeutics, Inc. ( CTI. To discover, develop and market novel and glycoengineered protein therapeutic drugs based upon the proprietary GlycoPolymer technology platform invented at CTI. Aequus is currently funded through a convertible note held by CTI. An Aequus Corporate Fact Sheet (PDF). Is available for download.

5

Aequus BioPharma - May 14, 2007

http://www.aequusbiopharma.com/news_10Dec12.html

Aequus BioPharma Appoints Ronald J. Berenson, M.D.,. Experienced industry entrepreneur to expand Aequus’ product development opportunities. SEATTLE, Wash., December 10, 2012. Aequus BioPharma, a majority owned subsidiary of Cell Therapeutics, Inc., announced today that Ronald J. Berenson, M.D. was appointed President and CEO of Aequus. In his new position, Dr. Berenson will expand business and product development opportunities for Aequus’ GlycoPolymer technology. Aequus ...About Aequus BioPharma, Inc.

UPGRADE TO PREMIUM TO VIEW 4 MORE

TOTAL PAGES IN THIS WEBSITE

9

OTHER SITES

aequusagarwood.com

Aequus Agarwood | Aequus Agarwood

An attempt at several updates in one. May 7, 2015 Aequus Blog. No matter how futile most of this will ultimately (most likely) be… we’re still fighting…. Apr 30, 2015 Aequus Blog. I will remove this later but I’m having problems with the link to the Blogs… this is a test post. Edited with BlogPad. A Peek Behind the Curtain. Mar 14, 2015 Aequus Blog. Ringing In The Changes. Feb 17, 2015 Aequus Blog. Loyalty to a bankrupt cause is not a moral imperative…. Jan 23, 2015 Aequus Blog. And so to re-Blog….

aequusam.com

Web hosting provider - Justhost.com - domain hosting - PHP Hosting - cheap web hosting - Frontpage Hosting E-Commerce Web Hosting Justhost

Web Hosting from Just Host. Design By Design Fusions.

aequusanimus.com

Home | AEQUUS ANIMUS

aequusarchers.co.uk

Aequus - East Midlands Archery Club

How to find us.

aequusattorneys.com

aequusbiopharma.com

Aequus BioPharma - Home

A proprietary recombinant DNA approach to creating novel therapeutic protein drugs by extending the plasma half-life of proteins and peptides which possess poor inherent pharmacokinetic properties. Aequus BioPharma, Inc. 3101 Western Ave. Suite 600. Seattle, WA 98121. Aequus’ GlycoPolymer technology allows scientists to create novel biopharmaceuticals that require less frequent injections (i.e., monthly rather than daily) due to their improved pharmacokinetic properties.

aequusblog.blogspot.com

AEQUUS PERU

Lunes, 30 de diciembre de 2013. Aequus] Editorial del Grupo Pacífico - Hno. Pedro Ferreira. PERÚ PROGRESO PARA TODOS. Es un buen deseo en forma permanente y con mayor objetividad para el año que comienza 2014, con todos sus avatares mundiales globalizados, y con nuestros propios problemas políticos, sociales y económicos, que se requiere de un desprendimiento con vocación de servicio. El mayor recurso de inversión pública, lo tiene el Estado peruano, y los Gobiernos Regionales, administrar recursos obede...

aequusboats.com

Aequus Boat - Home

Aequus 7.o answers the needs of pleasure boat users without the constraint of a permit (depending on national regulations). She can board a crew of up to 7 persons on a reposeful trip at sea, on a lake or a river with family and friends. Aequus 7.o offers all comfort a modern day-boat needs. Starting with an external kitchen, running water, a double berth, WC, shower. Aequus 7.o offers an attractive alternative to the constraints of sailboats and those of traditional motor-boating. You do not dep...2009 ...

aequuscon.com

Site Unavailable

This site is currently unavailable.

aequusconsulting.com

Aequusconsulting.com

aequuscontracting.com

AEQUUS

More site information coming soon, until then please contact,.